Index your Journal on RJRIndex — A product by ResearchJournalRank.com Index Now
34,970+ Journals Indexed Journal Suggester  |  Paper Finder  |  Compare Journals
Home › Multiple Sclerosis and Related Disorders

Multiple Sclerosis and Related Disorders

Q1 Journal Scopus Active Journal
Country
Netherlands
Western Europe
Subject Area and Category
Medicine
└ Medicine (miscellaneous) Q1
└ Neurology Q2
└ Neurology (clinical) Q2
Publisher
SJR 2025
0.959
Q1
SJR Score
H-Index
77
Citations / Doc (2yr)
2.82
Total Docs. (latest)
523
Total Citations (3yr)
5,089
Publication type
Journals
ISSN
22110356, 22110348
Coverage
2012-2026
Journal Rank
#5,225
Advertisement

Subject Categories

Medicine (miscellaneous) Q1
Neurology Q2
Neurology (clinical) Q2

Aims & Scope

Multiple Sclerosis is an area of ever expanding research and escalating publications. Multiple Sclerosis and Related Disorders is a wide ranging international journal supported by key researchers from all neuroscience domains that focus on MS and associated disease of the central nervous system. The primary aim of this new journal is the rapid publication of high quality original research in the field. Important secondary aims will be timely updates and editorials on important scientific and clinical care advances, controversies in the field, and invited opinion articles from current thought leaders on topical issues. One section of the journal will focus on teaching, written to enhance the practice of community and academic neurologists involved in the care of MS patients. Summaries of key articles written for a lay audience will be provided as an on-line resource. A team of four chief editors is supported by leading section editors who will commission and appraise original and review articles concerning: clinical neurology, neuroimaging, neuropathology, neuroepidemiology, therapeutics, genetics / transcriptomics, experimental models, neuroimmunology, biomarkers, neuropsychology, neurorehabilitation, measurement scales, teaching, neuroethics and lay communication.

Abstracting & Indexing

Scopus Google Scholar Web of Science Medline Embase

Detailed Metrics

Total Docs. (latest) 523
Total Docs. (3 years) 1,777
Total Refs. 20,650
Total Citations (3 years) 5,089
Citable Docs. (3 years) 1,589
Citations / Doc. (2 years) 2.82
Ref. / Doc. 39.48
% Female 50.0%

Metrics Visualization

Latest year data vs 3-year cumulative figures

Publication & Citation Trend

Loading trend data from Crossref...

Top 10 Most Cited Articles

Loading articles...

Frequently Asked Questions

What is the impact factor of Multiple Sclerosis and Related Disorders?

The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Multiple Sclerosis and Related Disorders has an SJR of 0.959 and is ranked Q1.

What is the SJR and quartile of Multiple Sclerosis and Related Disorders?

Multiple Sclerosis and Related Disorders has an SJR (SCImago Journal Rank) of 0.959 and its best quartile is Q1.

What is the H-index of Multiple Sclerosis and Related Disorders?

The H-index of Multiple Sclerosis and Related Disorders is 77, meaning 77 of its articles have each been cited at least 77 times.

Is Multiple Sclerosis and Related Disorders indexed in Scopus?

Yes. Multiple Sclerosis and Related Disorders is active in Scopus (Scopus Source List, August 2026).

Advertisement

Journal Information

SJR0.959
Best QuartileQ1
H Index77
ISSN22110356, 22110348
PublisherElsevier B.V.
CountryNetherlands
RegionWestern Europe
Coverage2012-2026
Open AccessNo
TypeJournal
Rank#5,225

Similar Journals

View all Medicine journals

Embed This Journal

Add this journal's ranking badge to your website:

<iframe src="https://researchjournalrank.com/widget.php?id=4460" style="border:1px solid #e0e0e0;border-radius:8px;width:100%;max-width:320px;height:200px" frameborder="0"></iframe>
Preview:

Researcher Reviews

Write a Review

No reviews yet for this journal.

Be the first to share your experience!

Share Your Experience

Your review will be published after moderation. Email will not be displayed publicly.

★ ★ ★ ★ ★
★ ★ ★ ★ ★
★ ★ ★ ★ ★
★ ★ ★ ★ ★